Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 91
Selected: 0
NCT IDTitle
NCT01131624Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
NCT05034250Iron Status in Female Infertility and Recurrent Miscarriage
NCT01100879Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
NCT03047954Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis
NCT03010072The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum
NCT05786469Patiromer Trial in CKD Stage IIIB to V
NCT01452906A Drug-Drug Interaction Study of Omeprazole and PA21
NCT06256991Potassium Correction for RAAS Optimization in Chronic Kidney Disease
NCT03888066Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
NCT05885763Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis
NCT03087058Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
NCT01975272The Use of Iron Therapy for Patients With Anemia After Caesarean Section
NCT00746551Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment
NCT04938635Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia
NCT02232906Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
NCT00810004Maintenance Treatment of Iron Deficiency in IBD Patients
NCT00882414Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
NCT00821717EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
NCT02846896The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
NCT05885737Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT04616092Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
NCT05514951Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
NCT02937454Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
NCT01057004EVIdence Based TreAtment - Heart Failure (EVITA-HF)
NCT02147795The German Patient Blood Management Network
NCT05524467Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
NCT06593392Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT05861492FDDA Utilization Study (FDDAU)
NCT01464190A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT01477424A Drug-Drug Interaction Study of Warfarin and PA21
NCT03071263Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
NCT05077436Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects
NCT02557477Omega 3/6 Fatty Acids for Reading in Children
NCT01110356Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age
NCT00414128Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
NCT01438359A Drug-Drug Interaction Study of Furosemide and PA21
NCT00994318Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
NCT03591406To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia
NCT02694744Patiromer With or Without Food for the Treatment of Hyperkalemia
NCT00824460Study of Phosphate Levels in Patients With Chronic Kidney Disease
NCT01820949Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients
NCT03214627Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial
NCT01371747Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
NCT03781089Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
NCT04364269Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia
NCT04817670Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
NCT01513369Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
NCT03769441Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation
NCT01453608A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
NCT04510792IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors